Amendment and Mail Process Complete

BYONDIS

Synthon Biopharmaceuticals B.V

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88585560 FILING DATE 08/20/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY MCCAULEY, BRENDAN D
L.O. ASSIGNED 114

PUB INFORMATION

RUN DATE 12/03/2019
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 12/02/2019
LITERAL MARK ELEMENT BYONDIS

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D NO 44D NO
44E YES 44E YES 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT BYONDIS
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Synthon Biopharmaceuticals B.V
ADDRESS Microweg 22
CM Nijmegen, 6545
ENTITY 16-LTD LIAB CO
CITIZENSHIP Netherlands

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Biopharmaceutical preparations, substances and compositions, namely, antibacterial substances for medical purposes, antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases; Biopharmaceutical active substances, namely, antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases; biological and biochemical drug and cultures for medical use, namely, biological preparations for the treatment of cancer, cultures of microorganisms for medical use, and biological tissue cultures for medical purposes; biopharmaceutical active substances, namely, nutritive substances for microorganism cultures; biopharmaceutical components and ingredients, namely, plant and herb extracts sold as components of medicated cosmetics; orthopedic articles, namely, bone repair paste for use in orthopedic surgery; all of the above excluding for the treatment of neuromuscular diseases and disorders
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Surgical and medical devices, apparatus and instruments, namely, surgical instruments and apparatus, surgical devices and instruments, surgical apparatus and instruments, medical instruments for cutting tissue, and medical instrument for performing biopsies, medical fluid injectors, injection device for pharmaceuticals, syringes for medical purposes, disposable syringes for medical purposes; orthopedic articles, namely, orthopedic walkers, orthopedic supports, orthopedic braces and orthopedic cushions; injection apparatus for medical purposes, namely, injection needles and injection instruments with needles
INTERNATIONAL CLASS 035
          DESCRIPTION TEXT Providing office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; providing office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; business mediation of commercial transaction for others, mediation of contracts for the purchase and sale of products, and medication of agreements all in the field of the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration files
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Scientific and technological services and research relating thereto, namely, antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases and scientific research related thereto; scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files, namely, scientific research field of pharmaceuticals for pharmaceutical registration purposes; pharmaceutical research services and pharmaceutical consultancy services; biomedical research services and biomedical research consultancy; medical research and medical research consultancy; scientific laboratory services in the fields of chemistry and biology, antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases; scientific laboratory services; product development of pharmaceutical products and ingredients for pharmaceuticals; providing information relating to medical and scientific research in the field of pharmaceutical preparations; providing information on the results of clinical trials for pharmaceutical preparations; quality control of products for others to determine conformity with certification standards; laboratory research, namely, scientific and medical research; laboratory analysis in the field of chemistry and biology as related to pharmaceuticals; product research for the pharmaceutical industry; design of pharmaceuticals for the pharmaceutical industry; product research and development for others; drug discovery services; testing in the context of quality control, namely, material testing and product testing; conducting clinical trials for others in the field of pharmaceutical preparations; quality control for others in the field of pharmaceutical preparations; providing information and data relating product research and developments in the pharmaceutical, biopharmaceutical and medical fields

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 035 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO


FOREIGN INFORMATION
PRIORITY CLAIMED SEC. 44(D) ON Benelux
APPLICATION NO. 1399914
APPLICATION FILING DATE 07/30/2019
FOREIGN REG NO. 1399914
FOREIGN REG DATE 08/07/2019
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 07/30/2029
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
12/02/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 012
12/02/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 011
11/29/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 010
11/20/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 009
11/20/2019 GNRT F NON-FINAL ACTION E-MAILED 008
11/20/2019 CNRT R NON-FINAL ACTION WRITTEN 007
11/19/2019 DOCK D ASSIGNED TO EXAMINER 006
11/05/2019 AMPX O APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED 005
10/31/2019 ALIE A ASSIGNED TO LIE 004
10/25/2019 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED 003
09/05/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
08/23/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY E. Anthony Figg
CORRESPONDENCE ADDRESS E. ANTHONY FIGG
ROTHWELL, FIGG, ERNST & MANBECK, PC
607 14TH STREET NW
SUITE 800
WASHINGTON, DC 20005
DOMESTIC REPRESENTATIVE E. Anthony Figg

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed